Recorded Chinese product: 克霉唑喷雾剂克霉唑喷雾剂

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

克霉唑B是一种在国家药监局注册认定的药品。该药品含有克霉唑b-4dcaa4b8等成分。

该药品关联的活性成分包括:克霉唑b。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:广州白云山制药股份有限公司白云山何济公制药厂Chinese legal name: 广州白云山制药股份有限公司白云山何济公制药厂。

您可以探索含有相同成分的其他药品:克霉唑b-4dcaa4b8成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 克霉唑喷雾剂) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Manufacturers recorded for this product: 广州白云山制药股份有限公司白云山何济公制药厂Chinese legal name: 广州白云山制药股份有限公司白云山何济公制药厂.

Explore other medicines containing the same ingredient: 克霉唑b productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 克霉唑喷雾剂Recorded Chinese product: 克霉唑喷雾剂
  • 规格Specification: 1.5%1.5 %

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 广州白云山制药股份有限公司白云山何济公制药厂Chinese legal name: 广州白云山制药股份有限公司白云山何济公制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H44024461

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H44024461

Manufacturer

Chinese legal name: 广州白云山制药股份有限公司白云山何济公制药厂 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H44024461

生产企业

广州白云山制药股份有限公司白云山何济公制药厂(国产)

适应症

用于体癣、股癣、手癣、足癣、头癣以及皮肤念珠菌感染。

用法用量

外用。喷于患处,一日3-4次。

不良反应

用药部位如有烧灼感、红肿等情况应停药。

禁忌

对本品过敏者禁用。

注意事项

1.避免接触眼睛和其他黏膜(如口、鼻等)。
2.用药部位如有烧灼感、红肿等情况应停药,并将局部药物洗净,必要时向医师咨询。
3.孕妇及哺乳期妇女应在医师指导下使用。
4.治疗皮肤念珠菌感染时不应紧密包扎。
5.对本品过敏者禁用,过敏体质者慎用。
6.本品性状发生改变时禁止使用。
7.请将本品放在儿童不能接触的地方。
8.儿童必须在成人监护下使用。
9.如正在使用其他药品,使用本品前请咨询医师或药师。

贮藏

密封,阴凉干燥处

规格

1.5%

证据Evidence

  • 批准文号: 国药准字H44024461
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.